Lääkkeet
Uusi tutkimus antaa toivoa laihduslääkkeille alkoholismia vastaan
Raportoinut AI AI:n luoma kuva
Göteborgin yliopiston uusi tutkimus osoittaa, että tirzepatiidi, diabetes- ja laihduslääke Mounjaroon kuuluva vaikuttava aine, vähentää alkoholin kulutusta ja vastaavaa uudelleenpaluukäyttäytymistä rotilla ja hiirillä. Tämä perustuu aiempiin semaglutiidia Ozempicissä ja Wegovyssä koskeviin tutkimuksiin, jotka hillitsevät alkoholin kulutusta ihmisillä. Tutkijat toivovat samanlaisia vaikutuksia alkoholiriippuvuudesta kärsivillä potilailla.
Brazil's Fiocruz, through its Farmanguinhos unit, has begun fully domestic production of tacrolimus, an immunosuppressant to prevent organ transplant rejection. The milestone stems from a Product Development Partnership (PDP) with Brazilian firm Libbs, which acquired manufacturing technology from India's Biocon. Farmanguinhos now becomes the sole supplier to the SUS public health system.
Raportoinut AI
Colombia's Ministry of Health and Social Protection warned about the risks of excessive acetaminophen consumption among minors, known as the “acetaminophen challenge”. This social media-influenced practice leads to overdoses and severe liver and kidney damage.
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency have approved lenacapavir as pre-exposure prophylaxis (PrEP) for uninfected individuals at high risk. This antiretroviral drug is administered via subcutaneous injections every six months, providing an alternative to daily pills. The World Health Organization endorses its use in comprehensive prevention strategies.
Raportoinut AI
In chile's presidential runoff, candidates like Jeannette Jara have revived ideas to eliminate vat on drugs and end oncology waiting lists. These proposals aim to ease the high cost of medications, which accounts for 60% of out-of-pocket health spending. Experts see a chance for agreements that go beyond the election.